## Background. Abnormalities in chromosome llq13 regions have been frequently found in head and neck squamous carcinoma. Recent studies indicate that the PRAD-1 (also CCNDI), which encodes cyclin D1, is a putative oncogene that is an important component of this region. Methods. DNA was extracted
Human cyclin D1 oncogene and esophageal squamous cell carcinoma
β Scribed by Hiroshi Nakagawa; Lawrence Zukerberg; Kazumi Togawa; Stephen J. Meltzer; Tetsuro Nishihara; Anil K. Rustgi
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 971 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cyclin-D1 over-expression represents one of several common alterations in the G 1 -S transition associated with malignancies. Conclusive evidences indicate that cyclin D1 is a proto-oncogene and the gene is amplified or rearranged in different tumour types. Since very little is known about aberratio
## Abstract Overexpression of cyclin D1, a G1 cell cycle regulator, is often found in many different tumor types, including oral squamous cell carcinomas (SCC). Recent laboratory experiments have demonstrated that cyclin D1 levels can influence radiosensitivity in various cell lines. This study eva
## Abstract ## BACKGROUND It has been reported that __p53__ regulates the G2βM checkpoint transition through cyclin B1, and it has been suggested that __p53__ plays an important role in the development and progression of various malignancies. The objective of the current study was to clarify the r
## Abstract In order to investigate the value of ras oncogene expression as a prognostic indicator in esophageal squamous cell carcinoma, we evaluated the level of ras oncogene protein product (p21) in 52 specimens resected between 1977 and 1986. All patients were followed until death or for at lea
## Abstract Cyclin D1 is a wellβknown cell cycle regulator. Recently, its proβsurvival function has been revealed in several tumors. Because increasing expression of cyclin D1 is a common event in oral squamous cell carcinoma (OSCC) and has been correlated with cisplatin resistance, we investigated